RPG Life Sciences Ltd.

•
₹ 2,636.6-0.69%

2026-08-21

rpglifesciences.comBSE: 532983NSE: RPGLIFE
Market Cap₹ 4,401 Cr.
Current Price₹ 2,655
High / Low₹ 3,082 / 1,733
Stock P/E38.2
Book Value₹ 385
Price to Book5.05
Dividend Yield0.90 %
ROCE27.0 %
ROE20.3 %
Face Value₹ 8

Add ratio to table

ABOUT

KEY POINTS

PROS

  • Company is almost debt free
  • Latest quarter profit grew 162.1% YoY, showing strong momentum
  • Company has been maintaining a healthy dividend payout of 34.5%
  • Company comfortably covers its interest (88.1x coverage)

CONS

  • Receivables are growing faster than sales - a possible quality concern
  • Stock is trading at 5.1x its book value

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

EDIT COLUMNS
HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.NameCMP Rs.P/EMar Cap Rs.Cr.Div Yld %NP Qtr Rs.Cr.Qtr Profit Var %Sales Qtr Rs.Cr.Qtr Sales Var %ROCE %OPM %
1.SUNPHARMA1898.0037.65455393.780.842901.2326.5315299.8810.9819.1128.81
2.DIVISLAB8525.0077.37226311.960.35902.0065.503080.0027.8021.5140.75
3.TORNTPHARM5013.0087.43190678.410.76566.003.284921.0057.3219.2733.81
4.CIPLA1416.0033.94114392.010.92785.55-39.187119.284.1316.0016.73
5.ZYDUSLIFE1105.0024.42110224.170.09990.20-34.908017.0023.9721.3924.54
6.LUPIN2220.0018.36101506.150.811416.9816.018276.8934.2828.8629.59
7.MANKIND2391.0048.3498747.340.04574.0929.124030.5912.8913.2426.30
8.DRREDDY1171.0030.3397740.540.68435.60-69.108099.80-5.2113.7510.63
9.LAURUSLABS1807.0089.3097634.420.11362.07123.942026.3129.1018.2031.50
10.AUROPHARMA1615.1525.0392932.160.251032.0325.229150.3517.4412.7620.54
11.BIOCON414.30136.3267518.230.12136.8053.364336.0010.893.2619.54
12.RPGLIFE2661.2038.224401.360.90307.60162.121956.901267.6026.9922.12
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2024
173
124
Operating Profit
—
OPM %
—
Other Income
3
Interest
0
Depreciation
5
47
Tax %
25.51%
Net Profit
0
21
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Mar 2025
143
118
Operating Profit
—
OPM %
—
Other Income
5
Interest
0
Depreciation
5
135
Tax %
13.01%
Net Profit
0
71
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Jun 2025
169
139
Operating Profit
—
OPM %
—
Other Income
5
Interest
0
Depreciation
5
35
Tax %
25.80%
Net Profit
26
2
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Dec 2025
180
140
Operating Profit
—
OPM %
—
Other Income
3
Interest
0
Depreciation
5
29
Tax %
24.00%
Net Profit
22
13
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Mar 2026
177
144
Operating Profit
—
OPM %
—
Other Income
12
Interest
0
Depreciation
6
40
Tax %
25.62%
Net Profit
30
18
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Jun 2026
196
159
Operating Profit
—
OPM %
—
Other Income
5
Interest
1
Depreciation
6
41
Tax %
25.81%
Net Profit
31
2
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025
653
494
Operating Profit
173
OPM %
27
Other Income
14
Interest
2
Depreciation
21
233
Tax %
21
Net Profit
183
EPS
111
Dividend Payout %
22
Minority Interest
0
Share of Associates
0
Adjusted EPS
111
Minority Interest
0
Share of Associates
0
Adjusted EPS
111
Mar 2026
708
560
Operating Profit
174
OPM %
25
Other Income
26
Interest
2
Depreciation
21
154
Tax %
25
Net Profit
115
EPS
70
Dividend Payout %
34
Minority Interest
0
Share of Associates
0
Adjusted EPS
70
Minority Interest
0
Share of Associates
0
Adjusted EPS
70
TTM
722
582
Operating Profit
—
OPM %
—
Other Income
26
Interest
1
Depreciation
22
146
Tax %
25
Net Profit
109
EPS
—
Dividend Payout %
—
Minority Interest
0
Share of Associates
0
Adjusted EPS
—
Minority Interest
0
Share of Associates
0
Adjusted EPS
—

COMPOUNDED SALES GROWTH

10 Years:
—
5 Years:
—
3 Years:
—

COMPOUNDED PROFIT GROWTH

10 Years:
—
5 Years:
—
3 Years:
—

STOCK PRICE CAGR

10 Years:
20%
5 Years:
39%
3 Years:
31%
1 Year:
13%

RETURN ON EQUITY

10 Years:
—
5 Years:
—
3 Years:
—
Last Year:
20%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2026

Jul 9

₹ 3

Rs.24.0000 per share(300%)Final Dividend

2025

Jun 27

₹ 2.50

Rs.4.0000 per share(50%)Special Dividend

2025

Jun 27

₹ 0.50

Rs.4.0000 per share(50%)Special Dividend

2024

Jun 28

₹ 2

Rs.16.0000 per share(200%)Final Dividend

2023

Jul 21

₹ 1.50

Rs.12.0000 per share(150%)Final Dividend

2022

Jul 14

₹ 1.20

Rs.9.6000 per share(120%)Final Dividend

2021

Aug 13

₹ 0.90

Rs.7.2000 per share(90%)Dividend

2018

Jul 19

₹ 0.30

Rs.2.4000 per share(30%)Dividend

2017

Jul 13

₹ 0.35

Rs.2.8000 per share(35%)Dividend

2016

Mar 22

₹ 0.20

Rs.1.6000 per share(20%)Interim Dividend

Mar 2025
Equity Capital
13
517
Trade Payables
79
47
Total Liabilities
657
172
Capital Work in Progress
4
127
93
87
Cash & Bank
140
35
Total Assets
657
Total Debt
0
Net Working Capital
345
Contingent Liabilities
14
Book Value per Share
320.80
Face Value
8.00
Total Debt
0
Net Working Capital
345
Contingent Liabilities
14
Book Value per Share
320.80
Face Value
8.00
Mar 2026
Equity Capital
13
592
Trade Payables
97
91
Total Liabilities
793
197
Capital Work in Progress
20
85
124
117
Cash & Bank
192
60
Total Assets
793
Total Debt
20
Net Working Capital
399
Contingent Liabilities
18
Book Value per Share
366.05
Face Value
8.00
Total Debt
20
Net Working Capital
399
Contingent Liabilities
18
Book Value per Share
366.05
Face Value
8.00

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025
78
Cash from Investing
-42
Cash from Financing
-27
9
Free Cash Flow
78
OCF / Net Profit
0.42
Cumulative 5-Year FCF
0
OCF / Net Profit
0.42
Cumulative 5-Year FCF
0
Mar 2026
56
Cash from Investing
86
Cash from Financing
-21
122
Free Cash Flow
-5
OCF / Net Profit
0.49
Cumulative 5-Year FCF
0
OCF / Net Profit
0.49
Cumulative 5-Year FCF
0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025
EPS (₹)
110.80
Book Value (₹)
320.80
Dividend per Share (₹)
24.00
Cash EPS (₹)
123.76
Operating Margin %
22.69%
Net Margin %
26.15%
ROE %
34.54%
ROCE %
44.20%
27.90%
Debtor Days
45
Inventory Days
48
Payable Days
147
-54
Debt to Equity (x)
0.00x
Interest Coverage (x)
147.47x
3.88x
Revenue Growth %
0.00%
Operating Profit Growth %
0.00%
Net Profit Growth %
0.00%
0.00%
P/E (x)
20.55x
P/B (x)
7.10x
Dividend Yield %
1.05%
20.93x
Mar 2026
EPS (₹)
69.64
Book Value (₹)
366.05
Dividend per Share (₹)
24.00
Cash EPS (₹)
82.63
Operating Margin %
19.56%
Net Margin %
15.22%
ROE %
20.28%
ROCE %
26.99%
15.89%
Debtor Days
49
Inventory Days
52
Payable Days
138
-37
Debt to Equity (x)
0.03x
Interest Coverage (x)
88.12x
3.48x
Revenue Growth %
8.28%
Operating Profit Growth %
0.14%
Net Profit Growth %
-37.15%
-37.15%
P/E (x)
26.57x
P/B (x)
5.05x
Dividend Yield %
1.30%
16.64x

Shareholding Pattern

Numbers in percentages

TRADES
Jun 2024
72.81
1.15
2.61
Government
0.00
23.43
Sep 2024
72.81
1.35
3.43
Government
0.00
22.41
Dec 2024
72.95
1.30
4.04
Government
0.00
21.71
Mar 2025
72.95
1.46
4.12
Government
0.00
21.47
Jun 2025
72.95
1.35
4.47
Government
0.00
21.24
Sep 2025
72.95
1.11
4.68
Government
0.00
21.26
Dec 2025
72.95
1.00
5.02
Government
0.00
21.03
Mar 2026
72.95
0.87
5.43
Government
0.00
20.75
Jun 2026
72.95
0.95
6.66
Government
0.00
19.44

Documents

Announcements

Annual Reports

Credit Ratings

Nothing filed yet.

Concalls

  • Jul 2026

    TranscriptPPTREC

  • May 2026

    TranscriptPPTREC

  • Apr 2026

    TranscriptPPTREC